Furthermore, we confirmed the significant decrease in Zbtb18 mRNA and protein in liver biopsies from NAFLD patients (Fig. 1b & Supplementary Table 1). This evidence concerns the gene ZBTB18 and metabolic dysfunction-associated steatotic liver disease.